RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
RICHEMONT CREDIT SUISSE CREDIT SUISSE	BARRY CALLEBAUT BARRY CALLEBAUT BARRY CALLEBAUT	CLARIANT NOVARTIS NOVARTIS
More documents (860)	More documents (656)	More documents (618)
20F	AGM	INTERNAL CONTROL
UBS ABB Ltd NOVARTIS	CLARIANT VIFOR PHARMA VIFOR PHARMA	ROCHE LAFARGE HOLCIM LAFARGE HOLCIM
More documents (4)	More documents (85)	More documents (23)

PERMANENT INFORMATION

2022.01.12 | 07:00 | Permanent Information Releases / General Company News

ROCHE

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care - HTML (w)

2022.01.11 | 07:00 | Permanent Information Releases / General Company News

ROCHE

Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare - HTML (w)

2022.01.11 | 05:00 | Permanent Information Releases / General Company News

SIKA

SIKA MIT REKORDUMSATZ 2021 - WACHSTUM VON 17.1% - HTML (w)

2022.01.11 | 05:00 | Permanent Information Releases / General Company News

SIKA

SIKA POSTS RECORD SALES FOR 2021 - GROWTH OF 17.1% - HTML (w)

2022.01.10 | 07:15 | Permanent Information Releases / General Company News

NOVARTIS

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19 - HTML (w)

More documents (3797)

Financial transactions

2020.01.06 | 07:00 | Public offerings / Statement of purchases / sales

NOVARTIS

Novartis completes tender offer for all outstanding shares of The Medicines Company - HTML (w)

2019.12.09 | 07:03 | Public offerings / Statement of purchases / sales

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019 - HTML (w)

2019.12.05 | 07:00 | Public offerings / Press Releases during Offer Period

NOVARTIS

Novartis tender offer for The Medicines Company commences - HTML (w)

2019.10.29 | 07:00 | Public offerings / Information note / Note in response

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

2019.07.31 | 07:00 | Public offerings / Press Releases during Offer Period

ROCHE

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. - HTML (w)

More documents (39)